mTOR Inhibitors Synergize on Regression, Reversal of Gene Expression, and Autophagy in Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) affects more than half a million people worldwide and is the third most common cause of cancer deaths. Because mammalian target of rapamycin (mTOR) signaling is up-regulated in 50% of HCCs, we compared the effects of the U.S. Food and Drug Administration–approved mTOR-...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Thomas, Hala Elnakat, Mercer, Carol A., Carnevalli, Larissa S., Park, Jongsun, Andersen, Jesper B., Conner, Elizabeth A., Tanaka, Kazuhiro, Matsutani, Tomoo, Iwanami, Akio, Aronow, Bruce J., Manway, Liu, Maira, S. Michel, Thorgeirsson, Snorri S., Mischel, Paul S., Thomas, George, Kozma, Sara C.
Формат: Artigo
Язык:Inglês
Опубликовано: 2012
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3703151/
https://ncbi.nlm.nih.gov/pubmed/22539746
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.3003923
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы